|
1.
1.1
IDENTIFICATION
OF
THE
SUBSTANCE/MIXTURE
AND
OF
THE
COMPANY/UNDERTAKING
Product
identifiers
Product
name
Product
Number
Brand
Index-No.
CAS-No.
:
:
:
:
:
1,3-Butadiene
17932
Fluka
601-013-00-X
106-99-0
1.2
Relevant
identified
uses
of
the
substance
or
mixture
and
uses
advised
against
Identified
uses
:
Laboratory
chemicals,
Manufacture
of
substances 2.
2.1
2.2
HAZARDS
IDENTIFICATION
Classification
of
the
substance
or
mixture
Classification
according
to
Regulation
(EC)
No
1272/2008
[EU-GHS/CLP]
Flammable
gases
(Category
1)
Gases
under
pressure
(Liquefied
gas)
Carcinogenicity
(Category
1A)
Germ
cell
mutagenicity
(Category
1B)
Classification
according
to
EU
Directives
67/548/EEC
or
1999/45/EC
Extremely
flammable.
May
cause
cancer.
May
cause
heritable
genetic
damage.
Label
elements
Labelling
according
Regulation
(EC)
No
1272/2008
[CLP]
Pictogram
Signal
word
Hazard
statement(s)
H220
H280
H340
H350
Precautionary
statement(s)
P201
P210
Danger
Extremely
flammable
gas.
Contains
gas
under
pressure;
may
explode
if
heated.
May
cause
genetic
defects.
May
cause
cancer.
Obtain
special
instructions
before
use.
Keep
away
from
heat/sparks/open
flames/hot
surfaces.
-
No
smoking.
P308
+
P313
P410
+
P403
Supplemental
Hazard
IF
exposed
or
concerned:
Get
medical
advice/
attention.
Protect
from
sunlight.
Store
in
a
well-ventilated
place.
none
Statements
Restricted
to
professional
users.
According
to
European
Directive
67/548/EEC
as
amended.
Hazard
symbol(s)
R-phrase(s)
R45
R46
R12
S-phrase(s)
S53
S45
May
cause
cancer.
May
cause
heritable
genetic
damage.
Extremely
flammable.
Avoid
exposure
-
obtain
special
instructions
before
use.
In
case
of
accident
or
if
you
feel
unwell,
seek
medical
advice
immediately
(show
the
label
where
possible).
Restricted
to
professional
users.
2.3
3.
3.1
Other
hazards
-
none
COMPOSITION/INFORMATION
ON
INGREDIENTS
Substances
Molecular
Weight
Component
1,3-Butadiene
:
54,09
g/mol
Concentration
CAS-No.
EC-No.
Index-No.
106-99-0
203-450-8
601-013-00-X
-
4.
4.1
4.2
4.3
FIRST
AID
MEASURES
Description
of
first
aid
measures
General
advice
Consult
a
physician.
Show
this
safety
data
sheet
to
the
doctor
in
attendance.
If
inhaled
If
breathed
in,
move
person
into
fresh
air.
If
not
breathing,
give
artificial
respiration.
Consult
a
physician.
In
case
of
skin
contact
Wash
off
with
soap
and
plenty
of
water.
Consult
a
physician.
In
case
of
eye
contact
Flush
eyes
with
water
as
a
precaution.
If
swallowed
Do
NOT
induce
vomiting.
Never
give
anything
by
mouth
to
an
unconscious
person.
Rinse
mouth
with
water.
Consult
a
physician.
Most
important
symptoms
and
effects,
both
acute
and
delayed
Cholinesterase
inhibitors
can
cause
heavy
salivation
and
secretion
in
the
lungs,
lachrymation,
blurred
vision,
involuntary
defecation,
diarrhea,
tremor,
ataxia,
sweating,
hypothermia,
lowered
heart
rate,
and/or
a
fall
in
blood
pressure
as
a
result
of
their
action
at
cholinergic
nerve
sites.,
narcosis,
Headache,
Nausea,
Vomiting,
Dizziness,
Drowsiness,
Confusion.,
Weakness,
Muscle
cramps/spasms.,
Change
in
pupil
size.,
Tremors,
Seizures.,
Incoordination.,
Convulsions,
Coma
Indication
of
any
immediate
medical
attention
and
special
treatment
needed
no
data
available
5.
5.1
5.2
5.3
5.4
6.
6.1
6.2
6.3
6.4
7.
7.1
7.2
7.3
8.
8.1
8.2
FIREFIGHTING
MEASURES
Extinguishing
media
Suitable
extinguishing
media
Use
water
spray,
alcohol-resistant
foam,
dry
chemical
or
carbon
dioxide.
Special
hazards
arising
from
the
substance
or
mixture
Carbon
oxides
Advice
for
firefighters
Wear
self
contained
breathing
apparatus
for
fire
fighting
if
necessary.
Further
information
Use
water
spray
to
cool
unopened
containers.
ACCIDENTAL
RELEASE
MEASURES
Personal
precautions,
protective
equipment
and
emergency
procedures
Use
personal
protective
equipment.
Avoid
breathing
vapors,
mist
or
gas.
Ensure
adequate
ventilation.
Remove
all
sources
of
ignition.
Evacuate
personnel
to
safe
areas.
Beware
of
vapours
accumulating
to
form
explosive
concentrations.
Vapours
can
accumulate
in
low
areas.
Environmental
precautions
Prevent
further
leakage
or
spillage
if
safe
to
do
so.
Do
not
let
product
enter
drains.
Methods
and
materials
for
containment
and
cleaning
up
Clean
up
promptly
by
sweeping
or
vacuum.
Reference
to
other
sections
For
disposal
see
section
13.
HANDLING
AND
STORAGE
Precautions
for
safe
handling
Avoid
exposure
-
obtain
special
instructions
before
use.Avoid
inhalation
of
vapour
or
mist.
Keep
away
from
sources
of
ignition
-
No
smoking.Take
measures
to
prevent
the
build
up
of
electrostatic
charge.
Conditions
for
safe
storage,
including
any
incompatibilities
Store
in
cool
place.
Keep
container
tightly
closed
in
a
dry
and
well-ventilated
place.
Specific
end
uses
no
data
available
EXPOSURE
CONTROLS/PERSONAL
PROTECTION
Control
parameters
Components
with
workplace
control
parameters
Exposure
controls
Appropriate
engineering
controls
Handle
in
accordance
with
good
industrial
hygiene
and
safety
practice.
Wash
hands
before
breaks
and
at
the
end
of
workday.
Personal
protective
equipment
Eye/face
protection
Face
shield
and
safety
glasses
Use
equipment
for
eye
protection
tested
and
approved
under
appropriate
government
standards
such
as
NIOSH
(US)
or
EN
166(EU).
Skin
protection
Handle
with
gloves.
Gloves
must
be
inspected
prior
to
use.
Use
proper
glove
removal
technique
(without
touching
glove's
outer
surface)
to
avoid
skin
contact
with
this
product.
Dispose
of
contaminated
gloves
after
use
in
accordance
with
applicable
laws
and
good
laboratory
practices.
Wash
and
dry
hands.
The
selected
protective
gloves
have
to
satisfy
the
specifications
of
EU
Directive
89/686/EEC
and
the
standard
EN
374
derived
from
it.
Body
Protection
Complete
suit
protecting
against
chemicals,
Flame
retardant
antistatic
protective
clothing,
The
type
of
protective
equipment
must
be
selected
according
to
the
concentration
and
amount
of
the
dangerous
substance
at
the
specific
workplace.
Respiratory
protection
Where
risk
assessment
shows
air-purifying
respirators
are
appropriate
use
a
full-face
respirator
with
multi-purpose
combination
(US)
or
type
AXBEK
(EN
14387)
respirator
cartridges
as
a
backup
to
engineering
controls.
If
the
respirator
is
the
sole
means
of
protection,
use
a
full-face
supplied
air
respirator.
Use
respirators
and
components
tested
and
approved
under
appropriate
government
standards
such
as
NIOSH
(US)
or
CEN
(EU).
9.
9.1
PHYSICAL
AND
CHEMICAL
PROPERTIES
Information
on
basic
physical
and
chemical
properties
a)
b)
c)
d)
e)
f)
g)
h)
Appearance
Odour
Odour
Threshold
pH
Melting
point/freezing
point
Initial
boiling
point
and
boiling
range
Flash
point
Evaporation
rate
Form:
Liquefied
gas
no
data
available
no
data
available
no
data
available
Melting
point/range:
-109
°C
-4,9
°C
at
1.013
hPa
-
Tested
according
to
Annex
V
of
Directive
67/548/EEC.
-76
°C
-
closed
cup
-
Tested
according
to
Annex
V
of
Directive
67/548/EEC.
no
data
available
i)
Flammability
(solid,
gas)
no
data
available
j)
k)
l)
Upper/lower
flammability
or
explosive
limits
Vapour
pressure
Vapour
density
Upper
explosion
limit:
16,3
%(V)
Lower
explosion
limit:
1,4
%(V)
ca.2.400
hPa
at
20
°C
3.200
hPa
at
30
°C
5.700
hPa
at
50
°C
no
data
available
m)
Relative
density
no
data
available
n)
o)
p)
q)
r)
s)
t)
Water
solubility
Partition
coefficient:
n-
octanol/water
Autoignition
temperature
Decomposition
temperature
Viscosity
Explosive
properties
Oxidizing
properties
0,5
g/l
at
20
°C
-
Tested
according
to
Annex
V
of
Directive
67/548/EEC.
log
Pow:
1,85
at
23
°C
no
data
available
no
data
available
no
data
available
no
data
available
no
data
available
9.2
Other
safety
information
no
data
available
10.
10.1
10.2
10.3
10.4
10.5
10.6
11.
11.1
STABILITY
AND
REACTIVITY
Reactivity
no
data
available
Chemical
stability
no
data
available
Possibility
of
hazardous
reactions
no
data
available
Conditions
to
avoid
Heat.
Polymerisation
occurs
when
exposed
to
white
light,
ultraviolet
light
or
heat.
May
form
peroxides
of
unknown
stability.
Heat,
flames
and
sparks.
Extremes
of
temperature
and
direct
sunlight.
Incompatible
materials
Oxidizing
agents,
Oxygen,
Copper,
Copper
alloys,
Carbides,
Halogens,
Metal
oxides,
Metals
Hazardous
decomposition
products
Other
decomposition
products
-
no
data
available
TOXICOLOGICAL
INFORMATION
Information
on
toxicological
effects
Acute
toxicity
LD50
Oral
-
rat
-
5.480
mg/kg
LC50
Inhalation
-
rat
-
4
h
-
285
mg/l
Skin
corrosion/irritation
no
data
available
Serious
eye
damage/eye
irritation
no
data
available
Respiratory
or
skin
sensitization
no
data
available
Germ
cell
mutagenicity
In
vivo
tests
showed
mutagenic
effects
Carcinogenicity
Carcinogenicity
-
rat
-
Inhalation
Tumorigenic:Carcinogenic
by
RTECS
criteria.
Cardiac:Tumors.
Lungs,
Thorax,
or
Respiration:Tumors.
This
is
or
contains
a
component
that
has
been
reported
to
be
carcinogenic
based
on
its
IARC,
OSHA,
ACGIH,
NTP,
or
EPA
classification.
Human
carcinogen.
IARC:
1
-
Group
1:
Carcinogenic
to
humans
(1,3-Butadiene)
Reproductive
toxicity
Reproductive
toxicity
-
mouse
-
Inhalation
Effects
on
Fertility:
Post-implantation
mortality
(e.g.,
dead
and/or
resorbed
implants
per
total
number
of
implants).
Effects
on
Embryo
or
Fetus:
Extra
embryonic
structures
(e.g.,
placenta,
umbilical
cord).
Effects
on
Embryo
or
Fetus:
Fetotoxicity
(except
death,
e.g.,
stunted
fetus).
Developmental
Toxicity
-
rat
-
Inhalation
Specific
Developmental
Abnormalities:
Musculoskeletal
system.
Specific
target
organ
toxicity
-
single
exposure
no
data
available
Specific
target
organ
toxicity
-
repeated
exposure
no
data
available
Aspiration
hazard
no
data
available
Potential
health
effects
Inhalation
Ingestion
Skin
Eyes
May
be
harmful
if
inhaled.
May
cause
respiratory
tract
irritation.
May
be
harmful
if
swallowed.
May
be
harmful
if
absorbed
through
skin.
May
cause
skin
irritation.
May
cause
eye
irritation.
Signs
and
Symptoms
of
Exposure
Cholinesterase
inhibitors
can
cause
heavy
salivation
and
secretion
in
the
lungs,
lachrymation,
blurred
vision,
involuntary
defecation,
diarrhea,
tremor,
ataxia,
sweating,
hypothermia,
lowered
heart
rate,
and/or
a
fall
in
blood
pressure
as
a
result
of
their
action
at
cholinergic
nerve
sites.,
narcosis,
Headache,
Nausea,
Vomiting,
Dizziness,
Drowsiness,
Confusion.,
Weakness,
Muscle
cramps/spasms.,
Change
in
pupil
size.,
Tremors,
Seizures.,
Incoordination.,
Convulsions,
Coma
Additional
Information
RTECS:
Not
available
12.
12.1
ECOLOGICAL
INFORMATION
Toxicity
Toxicity
to
fish
LC50
-
other
fish
-
71,5
mg/l
-
24
h
12.2
12.3
12.4
12.5
12.6
13.
13.1
14.
14.1
Persistence
and
degradability
no
data
available
Bioaccumulative
potential
no
data
available
Mobility
in
soil
no
data
available
Results
of
PBT
and
vPvB
assessment
no
data
available
Other
adverse
effects
no
data
available
DISPOSAL
CONSIDERATIONS
Waste
treatment
methods
Product
Burn
in
a
chemical
incinerator
equipped
with
an
afterburner
and
scrubber
but
exert
extra
care
in
igniting
as
this
material
is
highly
flammable.
Offer
surplus
and
non-recyclable
solutions
to
a
licensed
disposal
company.
Contaminated
packaging
Dispose
of
as
unused
product.
TRANSPORT
INFORMATION
UN
number
14.2
ADR/RID:
1010
UN
proper
shipping
name
IMDG:
1010
IATA:
1010
ADR/RID:
IMDG:
IATA:
BUTADIENES,
STABILIZED
BUTADIENES,
STABILIZED
Butadienes,
stabilized
Passenger
Aircraft:
Not
permitted
for
transport
14.3
Transport
hazard
class(es)
ADR/RID:
2.1
14.4
Packaging
group
ADR/RID:
-
IMDG:
2.1
IMDG:
-
IATA:
2.1
IATA:
-
14.5
Environmental
hazards
14.6
15.
ADR/RID:
no
Special
precautions
for
user
no
data
available
REGULATORY
INFORMATION
IMDG
Marine
pollutant:
no
IATA:
no
This
safety
datasheet
complies
with
the
requirements
of
Regulation
(EC)
No.
1907/2006.
15.1
15.2
16.
Safety,
health
and
environmental
regulations/legislation
specific
for
the
substance
or
mixture
no
data
available
Chemical
Safety
Assessment
no
data
available
OTHER
INFORMATION
Further
information
The above information is believed to be correct but does not purport to be all inclusive and
shall be used only as a guide. The information this document is based on the resent state
of our knowledge and is applicable to the product with regard to appropriate safety precautions.
It does not represent any guarantee of the properties of the product. Lookchem shall not be
held liable for any damage resulting from handling or from contact with the above product.
See reverse side of invoice or packing slip for additional terms and conditions of sale.
| 
1,3-Butadiene
China (Mainland)] 
Assessed
Assessed
Assessed
Assessed
Assessed
Assessed
Assessed
Assessed
Premium
Premium